Miguel Gómez Álvarez/LinkedIn
Jun 13, 2026, 18:25
Miguel Gómez Álvarez: Reviewing Inflammation, Transplantation, and Gene Therapy in Hemoglobinopathies
Miguel Gómez Álvarez, Hematologist at Department of Hematology and Hemotherapy, Hospital Clínico San Carlos, Madrid, Spain, shared a post on X:
“This morning at the EHA, the hemoglobinopathies got an earlier start than HPN…
Excellent start reviewing inflammation in sickle cell disease and the transplant and gene therapy process in hemoglobinopathies.”
Stay updated with Hemostasis Today.
-
Jun 13, 2026, 18:24Ana Pedrero Gil: Why Factor XIII Deficiency Is Often Overlooked During Acute Bleeding
-
Jun 13, 2026, 18:23Tobias Degsell: Building Stronger Bridges Across Disciplines, Countries, and Perspectives at EHA 2026
-
Jun 13, 2026, 18:22Haemoglobinopathies, Innovation, Patient Experience, and Equitable Access at EHA 2026 – TIF
-
Jun 13, 2026, 18:21Thomas Stauch: Discussing the Future of ITP Research and Patient Care
-
Jun 13, 2026, 17:11Kim De Keersmaecker: Advancing Hematology Through Shared Expertise at EHA 2026
-
Jun 13, 2026, 17:03Nour Al-Mozain: The Evolving Role of Apheresis Across Clinical Practice
-
Jun 13, 2026, 16:45Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026
-
Jun 13, 2026, 16:43Akshat Jain: Bridging Innovation and Access in Hematology at EHGCON 2026
-
Jun 13, 2026, 16:21Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026